1. Home
  2. VSTA vs MDWD Comparison

VSTA vs MDWD Comparison

Compare VSTA & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTA
  • MDWD
  • Stock Information
  • Founded
  • VSTA 1966
  • MDWD 2000
  • Country
  • VSTA Brazil
  • MDWD Israel
  • Employees
  • VSTA N/A
  • MDWD N/A
  • Industry
  • VSTA Other Consumer Services
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • VSTA Real Estate
  • MDWD Health Care
  • Exchange
  • VSTA Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • VSTA 187.6M
  • MDWD 184.8M
  • IPO Year
  • VSTA 2020
  • MDWD 2014
  • Fundamental
  • Price
  • VSTA $2.28
  • MDWD $16.72
  • Analyst Decision
  • VSTA Sell
  • MDWD Strong Buy
  • Analyst Count
  • VSTA 2
  • MDWD 1
  • Target Price
  • VSTA $3.00
  • MDWD $25.00
  • AVG Volume (30 Days)
  • VSTA 245.2K
  • MDWD 59.3K
  • Earning Date
  • VSTA 11-07-2024
  • MDWD 11-26-2024
  • Dividend Yield
  • VSTA N/A
  • MDWD N/A
  • EPS Growth
  • VSTA N/A
  • MDWD N/A
  • EPS
  • VSTA N/A
  • MDWD N/A
  • Revenue
  • VSTA $280,865,717.00
  • MDWD $19,720,000.00
  • Revenue This Year
  • VSTA $12.97
  • MDWD $10.37
  • Revenue Next Year
  • VSTA $11.26
  • MDWD $26.36
  • P/E Ratio
  • VSTA N/A
  • MDWD N/A
  • Revenue Growth
  • VSTA 6.41
  • MDWD N/A
  • 52 Week Low
  • VSTA $1.60
  • MDWD $11.04
  • 52 Week High
  • VSTA $4.32
  • MDWD $24.00
  • Technical
  • Relative Strength Index (RSI)
  • VSTA 50.61
  • MDWD 44.03
  • Support Level
  • VSTA $1.67
  • MDWD $17.33
  • Resistance Level
  • VSTA $2.38
  • MDWD $18.25
  • Average True Range (ATR)
  • VSTA 0.18
  • MDWD 0.79
  • MACD
  • VSTA 0.03
  • MDWD -0.13
  • Stochastic Oscillator
  • VSTA 83.56
  • MDWD 37.55

About VSTA Vasta Platform Limited

Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: